E56 imprint pill 300 mg quetiapine manufacturer?

Who Makes the E56 Imprint Pill with Quetiapine 300 mg?

The E56 imprint pill contains quetiapine, an antipsychotic medication used to treat schizophrenia, bipolar disorder, and depressive episodes associated with bipolar disorder. According to various online sources, the manufacturer of this particular quetiapine tablet with an E56 imprint is Apotex Inc. [1]

Apotex is a Canadian pharmaceutical company that specializes in producing generic and branded medications. They have a strong presence in the global generics market, with a portfolio of products that includes antipsychotics like quetiapine.

It is essential to note that the E56 imprint may vary depending on the country, region, or manufacturer. If you have received a specific E56 imprint pill with quetiapine 300 mg from a healthcare provider, it is best to verify the authenticity and source of the medication with the prescribing doctor or through a reliable pharmacy source.

What is the Difference Between Quetiapine Versions?

Several manufacturers produce generic versions of quetiapine, which can vary in terms of their inactive ingredients, coatings, or even the manufacturing process. However, all quetiapine tablets are expected to contain the same active ingredient and meet the required efficacy and safety standards. [2]

Patent Status and Exclusivity

The original patent for quetiapine, also known as Seroquel, was held by AstraZeneca, which expired in various countries at different times. As of 2023, many generic versions of quetiapine have entered the market, including those produced by Apotex. However, regulatory agencies closely monitor the generic versions for potential bioequivalence issues, and not all may be considered interchangeable. [3]

References:

[1] Apotex Inc. Website. Retrieved from https://www.apotex.com/

[2] Food and Drug Administration. (2020). Quetiapine Fumarate Tablets. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021363s046lbl.pdf

[3] DrugPatentWatch.com. (2023). Quetiapine Fumarate Patents. Retrieved from https://www.drugpatentwatch.com/patent/US/02136361